LEXINGTON, Mass.–(BUSINESS WIRE)–Théa Pharma Inc. (“Théa”), the US subsidiary of Europe’s leading independent pharmaceutical company specializing in the research, development and commercialization of eye care products, today announced the availability of iVIZIA line of over-the-counter (OTC) eye care products in the United States.
The iVIZIA OTC product line includes lubricating eye drops, lubricating eye gel and three options for the daily hygiene of sensitive eyelids. iVIZIA eye drops provide long-lasting relief and preservative-free ocular surface protection for patients with any type of dry eye, including those who wear contact lenses.1 The eye drops come in a patented multi-dose bottle developed by Théa that protects against contamination while reliably delivering only one calibrated drop at a time to avoid nuisance and waste caused by the runoff of drops encountered with many eye drops. other multi-dose vials. For very dry eyes, iVIZIA Eye Lubricating Gel is also available in preservative-free single-use bottles. Besides the inclusion of povidone, iVIZIA lubricating eye drops have the same formulation as Thealoz® Duo, the No. 1 dry eye drops prescribed in Europe. Eyecare professionals and their patients in the United States will also have access to three eyelid hygiene formulas that have become trusted global products. They gently remove oils and makeup from dry, irritated and sensitive eyelids: iVIZIA Eyelid Cleansing Wipes, iVIZIA Eyelid Micellar Cleanser and iVIZIA Eyelid Cleansing Gel. All three products are BAK-free and require no rinsing after use.
The iVIZIA brand is distributed by Colorado-based Similasan Corporation, known for its natural homeopathic products for eye, ear, sinus and cold relief. Théa and Similasan had previously formed a partnership of which Théa recently became the majority shareholder. The iVIZIA line is now available through Amazon and CVS and will hit the shelves of more than 26,000 retail stores by July. Eye Care Professionals can request samples by visiting the iVIZIA website www.IVIZIA.com/ecp.
“We are thrilled to partner with Similasan to provide eyecare professionals across the United States with a portfolio of new options for patients who need complete relief from dry eyes or eyelids – without preservatives that can damage the skin. ocular surface,” said Susan Benton, Managing Director, US Lead, Théa. “As a global driving force committed to advancing preservative-free treatments in eye care for the past 28 years, Théa wholeheartedly embraces this latest opportunity to improve the quality of life for patients in all areas of care. eyes with these innovative product offerings.
iVIZIA Eye Drops provide long-lasting dry eye relief by combining ingredients proven to target every point in the vicious dry eye cycle:
Povidone, the active ingredient to improve viscosity and provide moisturizing and lubricating properties;
Trehalose, a disaccharide that provides ocular bioprotection, osmoprotection and rehydration 4,5,6,7; and
Hyaluronic acid, a component of the tear film with the ability to lubricate, can bind 1000 times more water than its weight.
Clinical studies have shown that the combination of 3% trehalose and 0.15% hyaluronic acid found in both dry eye products:
increased tear thickness to 240 minutes from a single application 76 times longer than hyaluronic acid alone
provided the majority of patients with greater improvement in scores on the Ocular Surface Disease Index5 compared to hyaluronic acid alone
decreases inflammation of the ocular surface; and
relieves symptoms including blurred vision, stinging and itching.5
“As the first user of the iVIZIA product line, I have recommended the Lubricating Eye Drops to my patients who suffer from dry eye or experience dryness and discomfort while healing from surgery, and have received outstanding feedback and noted remarkable clinical improvements in those using iVIZIA,” said Mile Brujic, OD, FAAO of Bowling Green, Ohio. “I love that it’s formulated to target every point in the vicious cycle of eye dryness. The easy-to-use, preservative-free multi-dose vial is a great option for patients.”
1. Chen W, et al. Exp Eye Res. 2009;89(3):311-318.
2. Over-the-counter human ophthalmic drugs.
3. Jones L, et al. Eye Surf. 2017;15(3):575-628.
4. Aragona P, et al. Sci World J. 2014;2014:717835.
5. Chiambaretta F, et al. Eur J Ophthalmol. 2017;27(1):1-9.
6. Liu Z, et al. Invest Ophthalmol Vis Sci. 2020;61(10):26.
7. Schmidl D, et al. Cornea. 2015;34(4):421-426.
About Thea Pharma, Inc.
Established in Lexington, Massachusetts in 2019, Théa Pharma, Inc., is the US subsidiary of Théa. Its products include a suite of seven leading branded ophthalmic products, including Zioptan®AcellFx™, Cosopt®co-opt® PF, Azasite®Akten®and Betimol®, as well as the portfolio of iVIZIA dry eye drops and eyelid hygiene products distributed by Similasan Corporation. In addition, Théa Pharma is developing a preservative-free version of latanoprost, a drug against glaucoma, for which it filed a New Drug Application with the FDA in the first quarter of 2022. By focusing the passion and expertise of its parent company on the American market, Théa Pharma’s objective is to deliver uncompromising care that allows all players to look to the future of ophthalmic treatment with eyes wide open. To learn more, visit https://theapharmainc.com.
About Similasan Corporation, USA
Similasan is a Swiss leader in over-the-counter homeopathic products with a focus on eye and ear products with its North American headquarters just south of Denver, Colorado. Similasan and Thea have formed a joint venture to market the iVIZIA product line. Similasan homeopathic products are formulated according to traditional guidelines and produced under FDA Good Manufacturing Practices (GMP). To learn more, visit https://www.similasanusa.com.